Crossmark

Safety and efficacy of zanubrutinib in the management of chronic lymphocytic leukemia/small lymphocytic leukemia: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1007/s44337-025-00211-1

Published Online: 2025-01-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jamil, Abdur

Qureshi, Zaheer

Siddique, Rimsha

Altaf, Faryal

Kichloo, Asim
License Information

Text and Data Mining valid from 2025-01-30

Version of Record valid from 2025-01-30
More Information

Article History

Received: 8 August 2024

Accepted: 15 January 2025

First Online: 30 January 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below